In addition, significantly higher levels of CD19+CD24hiCD38hi B regulatory cells with cMYC+ and AICDA+ phenotypes were identified in HIV-positive pre-NHL compared to HIV-positive cART-naïve individuals [49]. This evidence concerns the gene AICDA and non-Hodgkin lymphoma.